39933002: Pancreatic hormone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Pancreatic hormone

\Drug or medicament (substance)\Hormone\Pancreatic hormone

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Pancreatic hormone

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Pancreatic hormone

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pancreatic hormone	Is a	Hormone	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Pancreatic hormone	Is a	Peptide hormones and their metabolites and precursors	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Pancreatic hormone	Has disposition	Pancreatic hormone (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Pancreatic hormone	Is a	Peptide hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Pancreatic hormone	Is a	Substituted amide (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane human 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane human 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 50/50 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 15/85 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 10/90 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane human 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble bovine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble porcine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane porcine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane human 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane bovine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 40/60 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble human 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble porcine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane bovine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble human 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100units/mL injection solution 3mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic porcine 30/70 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble human 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin zinc suspension mixed human 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100units/mL injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin aspart (recombinant human insulin analogue) 100units/ml inject	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin soluble bovine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Pork insulin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100iu/mL injection cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100iu/mL injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glargine 100iu/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Human isophane insulin 100units/mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing insulin glulisine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing insulin lispro and insulin lispro protamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Isophane insulin nph + human recombinant insulin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing isophane insulin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Isophane insulin nph	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin glulisine 100units/mL injection 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin human 100units/mL buffered regular solution injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fish insulin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing insulin detemir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin detemir 100iu/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin detemir 100iu/mL injection cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Insulin	Is a	True	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Amylin (substance)	Is a	True	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing amylin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing pramlintide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Pramlintide 0.6mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Free insulin	Is a	False	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Recombinant human glucagon	Is a	True	Pancreatic hormone	Inferred relationship	Existential restriction modifier (core metadata concept)

Start Page 2 of 2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66522017	Pancreatic hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
776481015	Pancreatic hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
66522017	Pancreatic hormone	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
66522017	Pancreatic hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
776481015	Pancreatic hormone (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
776481015	Pancreatic hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core